We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CVS market cap is 83.93B. The company's latest EPS is USD 3.6596 and P/E is 18.01.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 93.81B | 88.44B | 91.23B | 95.43B | 97.71B |
| Operating Income | 3.37B | 2.27B | 3.05B | 832M | 2.37B |
| Net Income | 2.05B | 1.11B | 1.77B | 87M | 1.64B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 268.71B | 292.11B | 322.47B | 357.78B | 372.81B |
| Operating Income | 13.91B | 14.55B | 10.28B | 14.09B | 8.52B |
| Net Income | 7.19B | 7.91B | 4.15B | 8.34B | 4.61B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 249.73B | 249.74B | 252.48B | 252.43B | 253.22B |
| Total Liabilities | 173.09B | 175.59B | 177.37B | 177.32B | 177.49B |
| Total Equity | 76.64B | 74.15B | 75.11B | 75.11B | 75.73B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 230.72B | 233B | 228.28B | 249.73B | 253.22B |
| Total Liabilities | 161.01B | 157.62B | 156.96B | 173.09B | 177.49B |
| Total Equity | 69.7B | 75.38B | 71.32B | 76.64B | 75.73B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 13.43B | 4.9B | 7.99B | 7.25B | 9.11B |
| Investing | -20.89B | -2.09B | -3.72B | -7.07B | -7.61B |
| Financing | 2.68B | -1.23B | 22M | -1.57B | -1.14B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 15.87B | 18.27B | 16.18B | 13.43B | 9.11B |
| Investing | -5.53B | -5.26B | -5.05B | -20.89B | -7.61B |
| Financing | -8.16B | -11.36B | -10.52B | 2.68B | -1.14B |
| Market Cap | 83.93B |
| Price to Earnings Ratio | 18.01 |
| Price to Sales Ratio | 0.22 |
| Price to Cash Ratio | 9.68 |
| Price to Book Ratio | 1.1 |
| Dividend Yield | 4.00% |
| Shares Outstanding | 1.26B |
| Average Volume (1 week) | 9.15M |
| Average Volume (1 Month) | 11.58M |
| 52 Week Change | -1.30% |
| 52 Week High | 71.45 |
| 52 Week Low | 43.56 |
| Spread (Intraday) | 0.59 (0.89%) |
| Company Name | CVS Health Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cvshealth.com |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
